서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 7 of 7

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2014-09	Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer Lee, Keun-Wook; Kim, Yu Jung; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Choi, In Sil; Kim, Jee Hyun Cancer Chemotherapy and Pharmacology, Vol.74 No.3, pp.447-455	DOI
2015-07	Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02) Park, Yeon Hee; Jung, Kyung Hae; Im, Seock-Ah; Sohn, Joo Hyuk; Ro, Jungsil; Ahn, Jin-Hee; Kim, Sung-Bae; Nam, Byung-Ho; Oh, Do Youn; Han, Sae-Won; Lee, Soohyeon; Park, In Hae; Lee, Keun Seok; Kim, Jee Hyun; Kang, Seok Yun; Lee, Moon Hee; Park, Hee Sook; Woo, Sook Young; Jung, Sin-Ho; Ahn, Jin Seok; Im, Young-Hyuck Breast Cancer Research and Treatment, Vol.152 No.1, pp.77-85	DOI
2018-12	Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy Jeon, Seung Hyuck; Shin, Kyung Hwan; Kim, Jin Ho; Kim, Kyubo; Kim, In Ah; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.172 No.3, pp.619-626	DOI
2019-11	Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11) Kim, Ji-Yeon; Lee, Eunjin; Park, Kyunghee; Im, Seock-Ah; Sohn, Joohyuk; Lee, Keun Seok; Chae, Yee Soo; Kim, Jee Hyun; Kim, Tae-Yong; Jung, Kyung Hae; Park, Yeon Hee Breast Cancer Research and Treatment, Vol.178 No.2, pp.367-377	DOI
2021-04	Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial Rugo, Hope S.; Im, Seock-Ah; Cardoso, Fatima; Cortes, Javier; Curigliano, Giuseppe; Musolino, Antonino; Pegram, Mark D.; Wright, Gail S.; Saura, Cristina; Escriva-de-Romani, Santiago; De laurentiis, Michelino; Levy, Christelle; Brown-Glaberman, Ursa; Ferrero, Jean-Marc; de Boer, Maaike; Kim, Sung-Bae; Petrakova, Katarina; Yardley, Denise A.; Freedman, Orit; Jakobsen, Erik H.; Kaufman, Bella; Yerushalmi, Rinat; Fasching, Peter A.; Nordstrom, Jeffrey L.; Bonvini, Ezio; Koenig, Scott; Edlich, Sutton; Hong, Shengyan; Rock, Edwin P.; Gradishar, William J. JAMA oncology, Vol.7 No.4, pp.573-584	DOI
2021-09	Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma Shitara, K.; Ozguroglu, M.; Bang, Y-J; Di Bartolomeo, M.; Mandala, M.; Ryu, M-H; Caglevic, C.; Chung, H. C.; Muro, K.; Van Cutsem, E.; Kobie, J.; Cristescu, R.; Aurora-Garg, D.; Lu, J.; Shih, C-S; Adelberg, D.; Cao, Z. A.; Fuchs, C. S. Annals of Oncology, Vol.32 No.9, pp.1127-1136	DOI
2022-08	Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2(- )ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study Cristofanilli, Massimo; Rugo, Hope S.; Im, Seock-Ah; Slamon, Dennis J.; Harbeck, Nadia; Bondarenko, Igor; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Iwata, Hiroji; O'Leary, Ben; Andre, Fabrice; Loibl, Sibylle; Bananis, Eustratios; Liu, Yuan; Huang, Xin; Kim, Sindy; Frean, Maria Jose Lechuga; Turner, Nicholas C. Clinical Cancer Research, Vol.28 No.16, pp.3433-3422	DOI

1